JP2018522064A5 - - Google Patents

Download PDF

Info

Publication number
JP2018522064A5
JP2018522064A5 JP2018517685A JP2018517685A JP2018522064A5 JP 2018522064 A5 JP2018522064 A5 JP 2018522064A5 JP 2018517685 A JP2018517685 A JP 2018517685A JP 2018517685 A JP2018517685 A JP 2018517685A JP 2018522064 A5 JP2018522064 A5 JP 2018522064A5
Authority
JP
Japan
Prior art keywords
hearing loss
composition
cell death
cdk
inner ear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018517685A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018522064A (ja
JP6902025B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/038384 external-priority patent/WO2016205806A1/en
Publication of JP2018522064A publication Critical patent/JP2018522064A/ja
Publication of JP2018522064A5 publication Critical patent/JP2018522064A5/ja
Application granted granted Critical
Publication of JP6902025B2 publication Critical patent/JP6902025B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018517685A 2015-06-18 2016-06-20 聴覚損失の予防および治療のための方法および組成物 Active JP6902025B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562181755P 2015-06-18 2015-06-18
US62/181,755 2015-06-18
PCT/US2016/038384 WO2016205806A1 (en) 2015-06-18 2016-06-20 Methods and compositions for the prevention and treatment of hearing loss

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020156803A Division JP7257367B2 (ja) 2015-06-18 2020-09-18 聴覚損失の予防および治療のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2018522064A JP2018522064A (ja) 2018-08-09
JP2018522064A5 true JP2018522064A5 (OSRAM) 2019-07-18
JP6902025B2 JP6902025B2 (ja) 2021-07-14

Family

ID=57546475

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018517685A Active JP6902025B2 (ja) 2015-06-18 2016-06-20 聴覚損失の予防および治療のための方法および組成物
JP2020156803A Active JP7257367B2 (ja) 2015-06-18 2020-09-18 聴覚損失の予防および治療のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020156803A Active JP7257367B2 (ja) 2015-06-18 2020-09-18 聴覚損失の予防および治療のための方法および組成物

Country Status (5)

Country Link
US (3) US20180161340A1 (OSRAM)
EP (2) EP3786164B1 (OSRAM)
JP (2) JP6902025B2 (OSRAM)
CN (2) CN108137595B (OSRAM)
WO (1) WO2016205806A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108137595B (zh) 2015-06-18 2021-04-20 听治疗有限责任公司 预防和治疗听力损失的方法和组合物
WO2018204226A1 (en) * 2017-05-03 2018-11-08 St. Jude Children's Research Hospital Compositions and methods for prevention and treatment of hearing loss
CN108685754A (zh) * 2018-07-30 2018-10-23 郑州兰茜生物工程有限公司 一种用于耳鸣及具有健耳舒耳功能的滴耳剂
KR102177610B1 (ko) * 2019-03-28 2020-11-11 단국대학교 천안캠퍼스 산학협력단 청각세포와의 공배양을 이용한 배아줄기세포의 내이 세포로의 분화 방법
EP4073102A4 (en) 2019-12-12 2024-05-08 Ting Therapeutics LLC Compositions and methods for the prevention and treatment of hearing loss
US20240350492A1 (en) * 2020-07-10 2024-10-24 Ting Therapeutics Llc Methods for the Prevention and Treatment of Hearing Loss
CN115223704A (zh) * 2022-03-03 2022-10-21 上海交通大学医学院附属第九人民医院 一种纯音听力图的自动识别与判断方法、装置及设备
WO2024058527A1 (ko) * 2022-09-13 2024-03-21 고려대학교 산학협력단 에스오메프라졸 또는 덱스란소프라졸을 유효성분으로 포함하는 난청 예방 또는 치료용 약학 조성물
WO2024215467A1 (en) * 2023-04-13 2024-10-17 Ting Therapeutics Llc Methods for the prevention and treatment of hearing loss

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3626187B2 (ja) 1993-06-07 2005-03-02 バイカル インコーポレイテッド 遺伝子治療に適するプラスミド
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
AU723325B2 (en) 1995-06-23 2000-08-24 President And Fellows Of Harvard College Transcriptional regulation of genes encoding vascular endothelial growth factor receptors
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US7132406B2 (en) 1998-02-23 2006-11-07 Sound Pharmaceuticals Incorporated Stimulation of cellular regeneration and differentiation in the inner ear
DK1471926T3 (da) 1999-06-01 2011-02-28 Baylor College Medicine Sammensætninger og fremgangsmåder til terapeutisk anvendelse af en atonal-associeret sekvens
FR2804959B1 (fr) 2000-02-15 2006-04-28 Centre Nat Rech Scient Utilisation de derives de paullones pour la fabrication de medicaments
AU2001251011A1 (en) * 2000-03-27 2001-10-08 The General Hospital Corporation Treatments for immune-mediated ear disorders
AU2001252458A1 (en) 2000-05-05 2001-11-20 Martin Bachmann Molecular antigen arrays and vaccines
US20020173507A1 (en) * 2000-08-15 2002-11-21 Vincent Santora Urea compounds and methods of uses
GB0025414D0 (en) 2000-10-16 2000-11-29 Consejo Superior Investigacion Nanoparticles
GB0205693D0 (en) * 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
US7206639B2 (en) 2002-03-15 2007-04-17 Sarcos Investments Lc Cochlear drug delivery system and method
US7867193B2 (en) 2004-01-29 2011-01-11 The Charles Stark Draper Laboratory, Inc. Drug delivery apparatus
US7612196B2 (en) 2002-11-14 2009-11-03 Dharmacon, Inc. siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
WO2004055154A2 (en) * 2002-12-17 2004-07-01 Centre National De La Recherche Scientifique (Cnrs) Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness
JP5022028B2 (ja) 2003-03-26 2012-09-12 サイトス・バイオテクノロジー・アクチェンゲゼルシャフト メラン−ａペプチドアナログ−ウイルス様粒子コンジュゲート
GB0317127D0 (en) * 2003-07-22 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
CA2532965C (en) * 2003-07-22 2013-05-14 Astex Therapeutics Limited 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
KR101281775B1 (ko) 2003-12-19 2013-07-15 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 소프트 또는 임프린트 리소그래피를 이용하여 분리된마이크로- 및 나노- 구조를 제작하는 방법
AU2005209331A1 (en) * 2004-01-30 2005-08-11 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
EP1768692B8 (en) 2004-07-01 2015-06-17 Yale University Targeted and high density drug loaded polymeric materials
US8404718B2 (en) * 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
WO2006117212A2 (en) 2005-05-04 2006-11-09 Develogen Aktiengesellschaft Use of gsk-3 inhibitors for preventing and treating pancreatic autoimmune disorders
US9265933B2 (en) 2005-09-08 2016-02-23 Massachusetts Eye And Ear Infirmary Cochlear implants containing biological cells and uses thereof
CN101374528A (zh) * 2006-01-20 2009-02-25 夸克医药公司 Rtp801的治疗用途
US7754700B2 (en) * 2006-04-24 2010-07-13 Trager Seymour F Composition and methods for alleviating symptoms of neurotoxicity
JP2009543771A (ja) * 2006-07-14 2009-12-10 アステックス・セラピューティクス・リミテッド 医薬化合物
JP2010509919A (ja) 2006-11-15 2010-04-02 マサチューセッツ・アイ・アンド・イア・インファーマリー 内耳細胞の生成
WO2008124165A2 (en) 2007-04-09 2008-10-16 Chimeros, Inc. Self-assembling nanoparticle drug delivery system
DE102007032579B4 (de) 2007-07-09 2017-05-04 Tyco Electronics Services Gmbh Endverschluss für die Telekommunikations- und Datentechnik
WO2009010298A2 (en) 2007-07-18 2009-01-22 Technische Universität Carolo-Wilhelmina Zu Braunschweig Paullone derivatives and its use
BRPI0817664A2 (pt) 2007-10-12 2015-03-24 Massachusetts Inst Technology Nanopartículas, método para preparar nanopartículas e método para tratar terapeuticamente ou profilaticamente um indivíduo
US9259399B2 (en) * 2007-11-07 2016-02-16 Cornell University Targeting CDK4 and CDK6 in cancer therapy
AU2008326431A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
US8004501B2 (en) 2008-01-21 2011-08-23 Sony Computer Entertainment America Llc Hand-held device with touchscreen and digital tactile pixels
EP2732819B1 (en) 2008-02-07 2019-10-16 Massachusetts Eye & Ear Infirmary Compounds that enhance Atoh-1 expression
US8496957B2 (en) * 2008-07-21 2013-07-30 Otonomy, Inc Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
WO2010047839A1 (en) 2008-10-25 2010-04-29 Aura Biosciences Modified plant virus particles and uses therefor
CA2743436C (en) 2008-11-24 2017-10-31 Massachusetts Eye & Ear Infirmary Pathways to generate hair cells
EP3299464B1 (en) 2010-05-26 2019-10-02 CuRNA, Inc. Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1
GB201107176D0 (en) * 2011-04-28 2011-06-15 Cxr Biosciences Ltd Pyrrolnitrin derivatives
WO2013071415A1 (en) * 2011-11-15 2013-05-23 University Health Network Targeting the rb pathway for the prevention of cancer
FR2993956B1 (fr) 2012-07-27 2015-05-22 Coutier Moulage Gen Ind Ensemble de tuyau pour l’ecoulement d’un fluide et d’un courant et procede pour assembler un tel ensemble de tuyau
EP2925859B1 (en) * 2012-11-29 2018-05-02 Takara Bio Europe AB Maturation of hepatocyte-like cells derived from human pluripotent stem cells
US9572815B2 (en) 2013-03-15 2017-02-21 St. Jude Children's Research Hospital Methods and compositions of p27KIP1 transcriptional modulators
CN108137595B (zh) 2015-06-18 2021-04-20 听治疗有限责任公司 预防和治疗听力损失的方法和组合物

Similar Documents

Publication Publication Date Title
JP2018522064A5 (OSRAM)
WO2016187201A3 (en) Antifungal compounds
EP3797109A4 (en) HETEROCYCLIC COMPOUNDS USED AS KINASE INHIBITORS, COMPOSITIONS COMPRISING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF
HK1251466A1 (zh) 包含pi3k抑制剂和hdac抑制剂的组合物
EP3672973A4 (en) HETEROCYCLIC COMPOUNDS USED AS KINASE INHIBITORS, COMPOSITIONS INCLUDING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF
HK1224296A1 (zh) 布罗莫结构域抑制剂
MX2020009234A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas con receptores de interleucina-1 (irak) tipo ii y usos de los mismos.
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
TN2020000082A1 (en) Oxy-fluoropiperidine derivative as kinase inhibitor
MX2015001571A (es) Compuestos de anillo en puente como inhibidores del virus de la hepatitis c (hcv) y sus aplicaciones farmaceuticas.
TN2020000125A1 (en) Amino-fluoropiperidine derivative as kinase inhibitor
EA201690127A1 (ru) Состав на основе ингибиторов syk
WO2019132561A8 (ko) 카이네이즈 저해제로서의 아미노-메틸피페리딘 유도체
EP3697791A4 (en) HETEROCYCLIC COMPOUNDS, COMPOSITIONS INCLUDING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF
NZ738229A (en) Delivery systems for controlled drug release
WO2011155803A3 (ko) 청각보호 작용을 하는 신규 화합물
WO2018136437A3 (en) Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
NZ775222A (en) Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
WO2018035346A8 (en) KINASE INHIBITING COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING CANCER
SA518390920B1 (ar) مركبات فينوكسي أسيتاميد معالجة بإضافة حلقة
MX2018014813A (es) Composiciones antibacterianas.
PH12021550304A1 (en) Novel medicament for treating inflammatory bowel disease
WO2018005444A3 (en) Methods for treating cancer
WO2017095950A3 (en) Compounds for treating proliferative diseases
WO2018166993A3 (en) PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF